Outcomes and Management Strategies for Capsule Retention: A Korean Capsule Endoscopy Nationwide Database Registry Study.
Capsule endoscopy
Retention
Small bowel
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
10
02
2019
accepted:
03
05
2019
pubmed:
12
5
2019
medline:
7
5
2020
entrez:
12
5
2019
Statut:
ppublish
Résumé
The most concerning complication of capsule endoscopy (CE) is capsule retention (CR) in the gastrointestinal (GI) tract; however, the clinical outcomes and management of patients with CR are still uncertain. This study aimed to investigate the clinical outcomes and management of CR. The outcomes of CR in multiple centers between October 2002 and June 2018 were retrospectively reviewed. Data on CE indication, findings, and management details were analyzed. A total of 2705 consecutive small-bowel CE procedures were performed. CR was detected in 20 cases (0.7%). The most common site of CR was the small bowel (19 cases), followed by the esophagus (one case). In patients who underwent CE, CR was detected in nine (0.6%) of 1397 patients with obscure GI bleeding. Further, CR occurred in 11 (6.5%) of 169 patients with Crohn's disease based on the final diagnoses after CE. Capsule retrieval was safely performed surgically in nine cases and endoscopically in six cases. The retained capsules dislodged after steroid treatment in two cases, whereas three cases of CR resolved without any intervention. In multivariate analysis, the development of abdominal symptoms after CR was a significant predictive factor for requiring endoscopic or surgical interventions for capsule extraction. This large multicenter study shows that CR is a rare complication with favorable clinical outcomes. Three-fourths of the patients with CR were managed with endoscopic or surgical intervention, which was required particularly in patients with abdominal symptoms after CR.
Sections du résumé
BACKGROUND
The most concerning complication of capsule endoscopy (CE) is capsule retention (CR) in the gastrointestinal (GI) tract; however, the clinical outcomes and management of patients with CR are still uncertain.
AIMS
This study aimed to investigate the clinical outcomes and management of CR.
METHODS
The outcomes of CR in multiple centers between October 2002 and June 2018 were retrospectively reviewed. Data on CE indication, findings, and management details were analyzed.
RESULTS
A total of 2705 consecutive small-bowel CE procedures were performed. CR was detected in 20 cases (0.7%). The most common site of CR was the small bowel (19 cases), followed by the esophagus (one case). In patients who underwent CE, CR was detected in nine (0.6%) of 1397 patients with obscure GI bleeding. Further, CR occurred in 11 (6.5%) of 169 patients with Crohn's disease based on the final diagnoses after CE. Capsule retrieval was safely performed surgically in nine cases and endoscopically in six cases. The retained capsules dislodged after steroid treatment in two cases, whereas three cases of CR resolved without any intervention. In multivariate analysis, the development of abdominal symptoms after CR was a significant predictive factor for requiring endoscopic or surgical interventions for capsule extraction.
CONCLUSIONS
This large multicenter study shows that CR is a rare complication with favorable clinical outcomes. Three-fourths of the patients with CR were managed with endoscopic or surgical intervention, which was required particularly in patients with abdominal symptoms after CR.
Identifiants
pubmed: 31076988
doi: 10.1007/s10620-019-05659-7
pii: 10.1007/s10620-019-05659-7
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3240-3246Références
Am J Gastroenterol. 2006 Oct;101(10):2218-22
pubmed: 16848804
Dig Dis Sci. 2008 Oct;53(10):2732-8
pubmed: 18320313
Gut. 2017 Apr;66(4):754-755
pubmed: 27247294
J Gastroenterol Hepatol. 2015 Jun;30(6):984-9
pubmed: 25594338
Gastrointest Endosc Clin N Am. 2006 Apr;16(2):229-50
pubmed: 16644453
United European Gastroenterol J. 2017 Aug;5(5):677-686
pubmed: 28815031
Gastrointest Endosc. 2011 Oct;74(4):834-9
pubmed: 21839995
Scand J Gastroenterol. 2009;44(10):1158-65
pubmed: 19606392
Endoscopy. 2015 Apr;47(4):352-76
pubmed: 25826168
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):886-90
pubmed: 21811157
Endoscopy. 2018 Apr;50(4):423-446
pubmed: 29539652
Gastroenterol Res Pract. 2012;2012:518718
pubmed: 21969823
Inflamm Bowel Dis. 2015 Sep;21(9):2158-64
pubmed: 26284295
Gastrointest Endosc. 2010 Feb;71(2):280-6
pubmed: 20152309
Scand J Gastroenterol. 2007 Sep;42(9):1127-32
pubmed: 17710681
Gastrointest Endosc. 2017 Jun;85(6):1157-1168.e2
pubmed: 28069475
J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):196-201
pubmed: 19561547
Endoscopy. 2016 Apr;48(4):373-9
pubmed: 26561918
Clin Endosc. 2017 Mar;50(2):148-160
pubmed: 28391667
Gastrointest Endosc. 2004 Jul;60(1):135-8
pubmed: 15229447
Endoscopy. 2005 Sep;37(9):808-15
pubmed: 16116530
Gastroenterology. 2017 Feb;152(3):497-514
pubmed: 28063287